You have 9 free searches left this month | for more free features.

liraglutide

Showing 26 - 50 of 523

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Obesity, Weight Loss Trial in Beirut (Dietary Intervention Med Diet, Dietary Intervention HP/LC Diet, Dietary Intervention LF

Recruiting
  • Obesity
  • Weight Loss
  • Dietary Intervention Med Diet
  • +2 more
  • Beirut, Riad El Solh, Lebanon
    American University of Beirut - Medical Center
Jul 19, 2022

Sleep Apnea, Obstructive Trial in Dublin (drug, device, combination product)

Active, not recruiting
  • Sleep Apnea, Obstructive
  • Liraglutide (Saxenda) 6Mg/Ml Inj Pen 3Ml
  • +2 more
  • Dublin, Dublin 4, Ireland
    St Vincent's University Hospital
Jan 28, 2022

Ischemic Stroke, Transient Ischemic Attack, Type 2 Diabetes Trial in Guangzhou (Liraglutide)

Recruiting
  • Ischemic Stroke
  • +2 more
  • Liraglutide
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Jinan University
Mar 17, 2022

Type2 Diabetes Trial in Charlottesville (Exercise, Liraglutide)

Recruiting
  • Type2 Diabetes
  • Exercise
  • Liraglutide
  • Charlottesville, Virginia
    University of Virginia
Mar 7, 2022

Diabetes, Type 2, Hemodialysis, Obese Trial in Paris, Saint-Ouen (Liraglutide)

Recruiting
  • Diabetes Mellitus, Type 2
  • +2 more
  • Liraglutide
  • Paris, Groupe Hospitalier Paris Saint-Joseph, France
  • +3 more
Mar 30, 2022

Obesity Trial in New York (Saxenda, Placebo)

Completed
  • Obesity
  • New York, New York
    New York University Medical Center
Feb 24, 2022

Obesity Trial in Ras al-Khaimah (POSE2.0 Endoscopic Gastric Remodeling, Liraglutide injection)

Recruiting
  • Obesity
  • POSE2.0 Endoscopic Gastric Remodeling
  • Liraglutide injection
  • Ras al-Khaimah, United Arab Emirates
    Ibrahim Bin Hamad Obaidullah Hospital
Jan 27, 2023

Healthy Trial in Singapore (LY3537021, Liraglutide, Placebo)

Active, not recruiting
  • Healthy
  • Singapore, Singapore
    Lilly Centre for Clinical Pharmacology
Nov 22, 2022

Type 2 Diabetes Trial in Changchun (Liraglutide injection, Victoza)

Completed
  • Type 2 Diabetes
  • Changchun, Jilin, China
    Affiliated Hospital of Changchun University of Traditional Chine
Aug 30, 2021

Type 1 Diabetes Trial in Idaho Falls, Seattle (Liraglutide, Golimumab)

Completed
  • Type 1 Diabetes Mellitus
  • Idaho Falls, Idaho
  • +1 more
Jan 21, 2022

Obesity Trial in Hamburg (GLP-1 (Liraglutide), Placebo)

Terminated
  • Obesity
  • GLP-1 (Liraglutide)
  • Placebo
  • Hamburg, Germany
    University Medical Center Hamburg
Jun 29, 2022

Overweight, Obesity Trial in United States (Semaglutide, Placebo (semaglutide), Liraglutide)

Completed
  • Overweight
  • Obesity
  • Birmingham, Alabama
  • +18 more
Apr 26, 2022

Fatty Liver, Nonalcoholic, Diabetes, Type 2 Trial in Alexandria (Metformin)

Active, not recruiting
  • Fatty Liver, Nonalcoholic
  • Diabetes Mellitus, Type 2
  • Alexandria, Egypt
    Alexandria University.
Jan 14, 2022

Obesity, Visceral, Cardiovascular Diseases, Fat Disorder Trial in Dallas (Liraglutide, Placebo)

Completed
  • Obesity, Visceral
  • +2 more
  • Liraglutide
  • Placebo
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Oct 20, 2021

Harmonizing RCT-Duplicate Emulations In A Real World Replication

Completed
  • Type 2 Diabetes Mellitus
  • Gothenburg, Sweden
    Research Site
Oct 23, 2023

Type 2 Diabetes Trial in Miami, Atlanta, New York (Liraglutide + OADs, Glargine + OADs)

Completed
  • Type 2 Diabetes
  • Liraglutide + OADs
  • Glargine + OADs
  • Miami, Florida
  • +4 more
Oct 5, 2021

(rPMS) Study of Xultophy® to Evaluate Safety and Effectiveness

Enrolling by invitation
  • Diabetes Mellitus, Type 2
  • Xultophy® (insulin degludec/liraglutide)
  • Daejeon, Cheongsa-ro, Seo-gu, Korea, Republic of
  • +9 more
Mar 21, 2022

Diabetes, Type 2 Treated With Insulin Trial in Bogotá (insulin degludec + liraglutide, Insulin Glargine - Insulin Aspart)

Recruiting
  • Diabetes Mellitus, Type 2 Treated With Insulin
  • insulin degludec + liraglutide
  • Insulin Glargine - Insulin Aspart
  • Bogotá, Colombia
    Hospital Universitario San Ignacio
Mar 2, 2023

Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (liraglutide, )

Completed
  • Metabolism and Nutrition Disorder
  • Obesity
  • liraglutide
  • placebo
  • Santa Monica, California
  • +31 more
Nov 18, 2022

Diabetes, Type 1, Type 1 Diabetes Trial in Aalborg (Placebo treatment, Liraglutide treatment)

Completed
  • Diabetes Mellitus, Type 1
  • Type 1 Diabetes Mellitus
  • Placebo treatment
  • Liraglutide treatment
  • Aalborg, Jutland, Denmark
    Mech-Sense, Department of Medical Gastroenterology, Aalborg Univ
Aug 9, 2021

Obesity Trial in Brisbane (XW003, Saxenda)

Recruiting
  • Obesity
  • Brisbane, Queensland, Australia
    Paratus Clinical Research Brisbane
Dec 6, 2021

Pre Diabetes, Polycystic Ovary Syndrome, Obesity Android Trial in Baton Rouge (Liraglutide Pen Injector [Saxenda], Placebo

Completed
  • Pre Diabetes
  • +2 more
  • Liraglutide Pen Injector [Saxenda]
  • Placebo Liraglutide Pen Injector
  • Baton Rouge, Louisiana
    Woman's Hospital
Jun 3, 2021

Type 2 Diabetes, Mild Cognitive Impairment Trial in Nanjing (Liraglutide, Empagliflozin, Linagliptin)

Recruiting
  • Type 2 Diabetes Mellitus
  • Mild Cognitive Impairment
  • Liraglutide
  • +2 more
  • Nanjing, Jiangsu, China
  • +1 more
Mar 28, 2022

Obesity Trial in Changsha (Liraglutide, Liraglutide;metformin)

Withdrawn
  • Obesity
  • Changsha, Hunan, China
    Xiangya Hospital of Central South University
Apr 8, 2021

Obesity, Obesity, Morbid Trial (Liraglutide Pen Injector)

Withdrawn
  • Obesity
  • Obesity, Morbid
  • Liraglutide Pen Injector
  • (no location specified)
Apr 22, 2021